STEMCELL TECHNOLOGIES GLOBAL SHOWCASE PRESENTATION How to Optimize Your Immune Cell Workflow—From Cell Isolation to Expansion
Thursday, June 1, 2023 12:30 PM - 12:45 PM
Global Showcase Theater
Global Showcase Presentation
How to Optimize Your Immune Cell Workflow—From Cell Isolation to Expansion
Presenter
Amanda Vanden Hoek, PhD, Director, Product Management, Immunology, STEMCELL Technologies, Canada
The development of safe and efficacious immune cell therapies requires a wide range of reliable tools and technologies. Addressing inefficient or sub-optimal conditions throughout the manufacturing process that would otherwise slow research progress and delay therapeutic programs can make successful bench-to-bedside transitions more common in the field. In this talk we will introduce how STEMCELL Technologies can help optimize your workflow—from cell sourcing and large-scale cell
isolation to activation and expansion—with robust, high-performance products and expert support. You will learn how to isolate or generate high yields of functional T and NK cells for cell therapy applications, without the use of serum or feeder cells. We will also discuss efficient gene editing strategies and solutions for immune cell generation from pluripotent stem cells or hematopoietic progenitors.
Presenter
Amanda Vanden Hoek, PhD, Director, Product Management, Immunology, STEMCELL Technologies, Canada
The development of safe and efficacious immune cell therapies requires a wide range of reliable tools and technologies. Addressing inefficient or sub-optimal conditions throughout the manufacturing process that would otherwise slow research progress and delay therapeutic programs can make successful bench-to-bedside transitions more common in the field. In this talk we will introduce how STEMCELL Technologies can help optimize your workflow—from cell sourcing and large-scale cell
isolation to activation and expansion—with robust, high-performance products and expert support. You will learn how to isolate or generate high yields of functional T and NK cells for cell therapy applications, without the use of serum or feeder cells. We will also discuss efficient gene editing strategies and solutions for immune cell generation from pluripotent stem cells or hematopoietic progenitors.
Amanda Vanden Hoek PhD
Director, Product Management, Immunology
StemCell Technologies Inc.
Presenter
Director, Product Management, Immunology
StemCell Technologies Inc.
Presenter